Kerry Group
EMEA
Tralee
,
Ireland
Multinational
FOUNDED
1972
HEADCOUNT
10000+
FUNDING
Public
Keywords:
fermentation, precision_fermentation, enzymes, biocatalysis, directed_evolution, probiotics, nutraceuticals, food_protein, dairy, bacteria, yeast, bioinformatics, omics, synthetic_biology, animal_nutrition
BUSINESS
Kerry Group plc, founded in 1972 and headquartered in Tralee, Ireland, is a publicly traded (Euronext Dublin and London) taste and nutrition ingredient company supplying flavors, food preservation, proactive health, and biotechnology solutions to food, beverage, and pharmaceutical customers in over 140 countries. Continuing operations revenue is approximately €8B with around 23,000 employees globally. Recent moves include the December 2024 transaction which effectively separated the dairy operations from the taste & nutrition + biotech ingredients business, the 2023 acquisition of the NOLA lactase enzyme business from Chr. Hansen/Novozymes, and the February 2022 acquisitions of c-LEcta (Leipzig, Germany) and Enmex (Mexico).
BIOTECH INVOLVEMENT
Operates a biotechnology platform spanning enzyme engineering, precision fermentation, strain development, and bioinformatics, anchored by c-LEcta's precision fermentation and biotransformation capabilities and Enmex's industrial enzyme manufacturing in Mexico. Sells enzymes into food, beverage, dairy, pharmaceutical bioprocessing, and animal nutrition markets; biotechnology is named as a strategic core capability in the 2025 Annual Report.
TECHNOLOGY PLATFORM
fermentation; microbial production; enzyme technology
PRIMARY PRODUCTS
Taste ingredients; functional nutrition solutions; enzymes and cultures